

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.85207425 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.85207425 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 9.18621312 |
| 4 | skeletal muscle contraction (GO:0003009) | 8.99416253 |
| 5 | skeletal muscle adaptation (GO:0043501) | 8.18209794 |
| 6 | actin-mediated cell contraction (GO:0070252) | 8.13319170 |
| 7 | regulation of relaxation of muscle (GO:1901077) | 8.08798903 |
| 8 | snRNA transcription (GO:0009301) | 7.95605103 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.94813765 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.78130433 |
| 11 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 6.74684438 |
| 12 | dosage compensation (GO:0007549) | 6.70673475 |
| 13 | centriole replication (GO:0007099) | 6.63180256 |
| 14 | skeletal muscle fiber development (GO:0048741) | 6.49112156 |
| 15 | barbed-end actin filament capping (GO:0051016) | 6.34851112 |
| 16 | actin filament-based movement (GO:0030048) | 6.29168628 |
| 17 | response to inactivity (GO:0014854) | 6.18575104 |
| 18 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 6.16293772 |
| 19 | myotube cell development (GO:0014904) | 5.47350574 |
| 20 | glycogen catabolic process (GO:0005980) | 5.46554624 |
| 21 | purine nucleotide salvage (GO:0032261) | 5.39044773 |
| 22 | cardiac myofibril assembly (GO:0055003) | 5.36804502 |
| 23 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 5.34617292 |
| 24 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 5.34617292 |
| 25 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.31237584 |
| 26 | creatine metabolic process (GO:0006600) | 5.20454464 |
| 27 | IMP metabolic process (GO:0046040) | 5.15464947 |
| 28 | regulation of centriole replication (GO:0046599) | 5.10473709 |
| 29 | glucan catabolic process (GO:0009251) | 5.09205227 |
| 30 | cornea development in camera-type eye (GO:0061303) | 5.02472488 |
| 31 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 5.00422534 |
| 32 | cardiac muscle contraction (GO:0060048) | 4.98139576 |
| 33 | striated muscle contraction (GO:0006941) | 4.97475253 |
| 34 | sarcomere organization (GO:0045214) | 4.90984818 |
| 35 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.84894302 |
| 36 | striated muscle atrophy (GO:0014891) | 4.81148052 |
| 37 | response to muscle activity (GO:0014850) | 4.73128891 |
| 38 | cellular polysaccharide catabolic process (GO:0044247) | 4.72649002 |
| 39 | skeletal muscle tissue development (GO:0007519) | 4.71454836 |
| 40 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 4.70566090 |
| 41 | plasma membrane repair (GO:0001778) | 4.65430308 |
| 42 | skeletal muscle tissue regeneration (GO:0043403) | 4.60204293 |
| 43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.53379943 |
| 44 | regulation of actin filament-based movement (GO:1903115) | 4.46282863 |
| 45 | regulation of cell communication by electrical coupling (GO:0010649) | 4.41766622 |
| 46 | polysaccharide catabolic process (GO:0000272) | 4.39907506 |
| 47 | centriole assembly (GO:0098534) | 4.37913721 |
| 48 | IMP biosynthetic process (GO:0006188) | 4.33875054 |
| 49 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 4.32248463 |
| 50 | cardiac muscle hypertrophy (GO:0003300) | 4.27835200 |
| 51 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.22129285 |
| 52 | myofibril assembly (GO:0030239) | 4.21091318 |
| 53 | ribonucleoprotein complex disassembly (GO:0032988) | 4.17748542 |
| 54 | glucan biosynthetic process (GO:0009250) | 4.17245068 |
| 55 | glycogen biosynthetic process (GO:0005978) | 4.17245068 |
| 56 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.11335396 |
| 57 | cellular response to dexamethasone stimulus (GO:0071549) | 4.09595477 |
| 58 | striated muscle adaptation (GO:0014888) | 4.08543379 |
| 59 | striated muscle hypertrophy (GO:0014897) | 4.08360043 |
| 60 | muscle atrophy (GO:0014889) | 4.07083206 |
| 61 | muscle cell cellular homeostasis (GO:0046716) | 4.02874325 |
| 62 | muscle contraction (GO:0006936) | 4.02534376 |
| 63 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.01910529 |
| 64 | neuronal action potential propagation (GO:0019227) | 4.01457541 |
| 65 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.92812062 |
| 66 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 3.92429219 |
| 67 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.88261153 |
| 68 | regulation of striated muscle contraction (GO:0006942) | 3.86054658 |
| 69 | response to dexamethasone (GO:0071548) | 3.84634618 |
| 70 | muscle structure development (GO:0061061) | 3.84315461 |
| 71 | ubiquinone biosynthetic process (GO:0006744) | 3.84311422 |
| 72 | cytoplasmic microtubule organization (GO:0031122) | 3.83441498 |
| 73 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.82375071 |
| 74 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230) | 3.81444429 |
| 75 | muscle organ development (GO:0007517) | 3.81267705 |
| 76 | negative regulation of muscle hypertrophy (GO:0014741) | 3.78757717 |
| 77 | carnitine shuttle (GO:0006853) | 3.77989760 |
| 78 | striated muscle cell development (GO:0055002) | 3.75674018 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 3.75297945 |
| 80 | cytidine metabolic process (GO:0046087) | 3.74640925 |
| 81 | cytidine catabolic process (GO:0006216) | 3.74640925 |
| 82 | cytidine deamination (GO:0009972) | 3.74640925 |
| 83 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.73470700 |
| 84 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.72804205 |
| 85 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.72804205 |
| 86 | muscle organ morphogenesis (GO:0048644) | 3.72330117 |
| 87 | glial cell proliferation (GO:0014009) | 3.67937994 |
| 88 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.66523535 |
| 89 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.66523535 |
| 90 | muscle hypertrophy (GO:0014896) | 3.65873088 |
| 91 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.65271953 |
| 92 | fructose metabolic process (GO:0006000) | 3.64220409 |
| 93 | muscle cell fate commitment (GO:0042693) | 3.63311272 |
| 94 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.62543962 |
| 95 | neuromuscular synaptic transmission (GO:0007274) | 3.60527250 |
| 96 | NADH metabolic process (GO:0006734) | 3.59274021 |
| 97 | adult heart development (GO:0007512) | 3.58916948 |
| 98 | eyelid development in camera-type eye (GO:0061029) | 3.58427615 |
| 99 | synaptonemal complex assembly (GO:0007130) | 3.56039072 |
| 100 | muscle system process (GO:0003012) | 3.55090073 |
| 101 | muscle tissue morphogenesis (GO:0060415) | 3.54255664 |
| 102 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.50692416 |
| 103 | synaptonemal complex organization (GO:0070193) | 3.49898951 |
| 104 | actomyosin structure organization (GO:0031032) | 3.49325705 |
| 105 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.49250896 |
| 106 | muscle fiber development (GO:0048747) | 3.48328040 |
| 107 | glycogen metabolic process (GO:0005977) | 3.48299564 |
| 108 | myoblast fusion (GO:0007520) | 3.45921696 |
| 109 | somite development (GO:0061053) | 3.44729644 |
| 110 | male genitalia development (GO:0030539) | 3.44203592 |
| 111 | cellular glucan metabolic process (GO:0006073) | 3.40501623 |
| 112 | glucan metabolic process (GO:0044042) | 3.40501623 |
| 113 | negative regulation of glial cell proliferation (GO:0060253) | 3.40295590 |
| 114 | ubiquinone metabolic process (GO:0006743) | 3.38107153 |
| 115 | cellular carbohydrate catabolic process (GO:0044275) | 3.34467472 |
| 116 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.34286679 |
| 117 | regulation of sequestering of triglyceride (GO:0010889) | 3.33846536 |
| 118 | positive regulation of myotube differentiation (GO:0010831) | 3.33455627 |
| 119 | otic vesicle formation (GO:0030916) | 3.33382395 |
| 120 | regulation of sarcomere organization (GO:0060297) | 3.32003643 |
| 121 | regulation of hexokinase activity (GO:1903299) | 3.30021131 |
| 122 | regulation of glucokinase activity (GO:0033131) | 3.30021131 |
| 123 | cardiac muscle cell development (GO:0055013) | 3.29705406 |
| 124 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.29316144 |
| 125 | gluconeogenesis (GO:0006094) | 3.28571115 |
| 126 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.28156899 |
| 127 | myotube differentiation (GO:0014902) | 3.28008098 |
| 128 | organelle disassembly (GO:1903008) | 3.27524512 |
| 129 | fatty acid transmembrane transport (GO:1902001) | 3.27129761 |
| 130 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.24708105 |
| 131 | striated muscle tissue development (GO:0014706) | 3.23776014 |
| 132 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.23468242 |
| 133 | negative regulation of muscle contraction (GO:0045932) | 3.21447321 |
| 134 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.20477310 |
| 135 | muscle adaptation (GO:0043500) | 3.20289559 |
| 136 | positive regulation of cation channel activity (GO:2001259) | 3.19640133 |
| 137 | muscle cell development (GO:0055001) | 3.19033575 |
| 138 | cardiac ventricle formation (GO:0003211) | 3.16751240 |
| 139 | positive regulation of myoblast differentiation (GO:0045663) | 3.16267632 |
| 140 | regulation of membrane repolarization (GO:0060306) | 3.15771696 |
| 141 | homeostasis of number of cells within a tissue (GO:0048873) | 3.13340659 |
| 142 | heart process (GO:0003015) | 3.12796308 |
| 143 | heart contraction (GO:0060047) | 3.12796308 |
| 144 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 3.12044378 |
| 145 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.11621319 |
| 146 | skeletal muscle cell differentiation (GO:0035914) | 3.11081009 |
| 147 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 3.09284284 |
| 148 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.04544277 |
| 149 | regulation of hippo signaling (GO:0035330) | 3.03641657 |
| 150 | regulation of coenzyme metabolic process (GO:0051196) | 3.03371393 |
| 151 | regulation of cofactor metabolic process (GO:0051193) | 3.03371393 |
| 152 | response to activity (GO:0014823) | 3.01189589 |
| 153 | protein localization to chromosome (GO:0034502) | 2.99530609 |
| 154 | cellular response to virus (GO:0098586) | 2.99495398 |
| 155 | modulation by virus of host process (GO:0019054) | 2.97400225 |
| 156 | sequestering of actin monomers (GO:0042989) | 12.6416136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.54374840 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.51563636 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.77768065 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.26657094 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.15737117 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.10614669 |
| 7 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.91060159 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.88597881 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.62021643 |
| 10 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.57431054 |
| 11 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.57348891 |
| 12 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.40050177 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.36869627 |
| 14 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.30184946 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.29378855 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.15613770 |
| 17 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.09450576 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.06168781 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.03898823 |
| 20 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.00557842 |
| 21 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.99068393 |
| 22 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.87208779 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.85821373 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.85164197 |
| 25 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76759497 |
| 26 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.75976351 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.75714327 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75520386 |
| 29 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.63360949 |
| 30 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.60974344 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59665315 |
| 32 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59557317 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57743605 |
| 34 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.56777177 |
| 35 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.56777177 |
| 36 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.56624966 |
| 37 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54500099 |
| 38 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53314178 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52390675 |
| 40 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52012276 |
| 41 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.51347429 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.50290495 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49854853 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49538329 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.48389649 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47177650 |
| 47 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.43361817 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39933472 |
| 49 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.39845547 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37575854 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36906014 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36679222 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36679222 |
| 54 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.36601514 |
| 55 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36031691 |
| 56 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.35449238 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31727432 |
| 58 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31287674 |
| 59 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.31275888 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30689058 |
| 61 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.30457824 |
| 62 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30316716 |
| 63 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.28796341 |
| 64 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.28488500 |
| 65 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27844310 |
| 66 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.26059800 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25336740 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25239549 |
| 69 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23809896 |
| 70 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23809896 |
| 71 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21994791 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.19055905 |
| 73 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18532641 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18532641 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18514307 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18374857 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17626942 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17486249 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17409030 |
| 80 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.17319068 |
| 81 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.11621903 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.10419446 |
| 83 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.08943860 |
| 84 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.08925949 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.08261085 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07717988 |
| 87 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07177507 |
| 88 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.07035920 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06923987 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05705166 |
| 91 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05501159 |
| 92 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04369191 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03642787 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03456734 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03421168 |
| 96 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03235096 |
| 97 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02898981 |
| 98 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.02858557 |
| 99 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01136119 |
| 100 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00811034 |
| 101 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99698708 |
| 102 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98966743 |
| 103 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98496638 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98456448 |
| 105 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.97677949 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97045574 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96461199 |
| 108 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96441902 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.96152468 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96019751 |
| 111 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94639406 |
| 112 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94134285 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.93930881 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93823525 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93548134 |
| 116 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93436204 |
| 117 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.92613667 |
| 118 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92240812 |
| 119 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92162457 |
| 120 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91495677 |
| 121 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91064108 |
| 122 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.90763661 |
| 123 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90523445 |
| 124 | UTX_26944678_Chip-Seq_JUKART_Human | 0.90322760 |
| 125 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.90121258 |
| 126 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89991966 |
| 127 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89645768 |
| 128 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89457466 |
| 129 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.89120724 |
| 130 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88920873 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88562299 |
| 132 | NFYB_21822215_ChIP-Seq_K562_Human | 0.88313301 |
| 133 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88240667 |
| 134 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.88022213 |
| 135 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87396205 |
| 136 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87313772 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87160721 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87124639 |
| 139 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86573467 |
| 140 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85759974 |
| 141 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.85430252 |
| 142 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85184569 |
| 143 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.85070320 |
| 144 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.84915914 |
| 145 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84858151 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.84656876 |
| 147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84607788 |
| 148 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84586388 |
| 149 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.84460427 |
| 150 | ERA_21632823_ChIP-Seq_H3396_Human | 0.84324971 |
| 151 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.84086244 |
| 152 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83320005 |
| 153 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83320005 |
| 154 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.83080209 |
| 155 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.82550494 |
| 156 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82478135 |
| 157 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.81049397 |
| 158 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.80974310 |
| 159 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.80960683 |
| 160 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80524365 |
| 161 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.80325483 |
| 162 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80293716 |
| 163 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.80154296 |
| 164 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79668822 |
| 165 | TBL1_22424771_ChIP-Seq_293T_Human | 0.79665825 |
| 166 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79557777 |
| 167 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.79550754 |
| 168 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.79101936 |
| 169 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.78764343 |
| 170 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77354581 |
| 171 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.76136374 |
| 172 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76087183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.01435727 |
| 2 | MP0003787_abnormal_imprinting | 6.20585100 |
| 3 | MP0000749_muscle_degeneration | 4.85388944 |
| 4 | MP0003646_muscle_fatigue | 4.75300162 |
| 5 | MP0000751_myopathy | 4.25242011 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.79094302 |
| 7 | MP0000747_muscle_weakness | 3.71034354 |
| 8 | MP0000759_abnormal_skeletal_muscle | 3.54967067 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.41841612 |
| 10 | MP0008877_abnormal_DNA_methylation | 3.24001496 |
| 11 | MP0005369_muscle_phenotype | 3.16396838 |
| 12 | MP0008789_abnormal_olfactory_epithelium | 3.06699582 |
| 13 | MP0002269_muscular_atrophy | 3.06606210 |
| 14 | MP0004130_abnormal_muscle_cell | 2.96158594 |
| 15 | MP0005451_abnormal_body_composition | 2.94617098 |
| 16 | MP0005187_abnormal_penis_morphology | 2.92168813 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.80815157 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.65765268 |
| 19 | MP0000733_abnormal_muscle_development | 2.45502797 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 2.36172001 |
| 21 | MP0004233_abnormal_muscle_weight | 2.25332877 |
| 22 | MP0003121_genomic_imprinting | 2.23353056 |
| 23 | MP0004134_abnormal_chest_morphology | 2.21040117 |
| 24 | MP0000750_abnormal_muscle_regeneration | 2.19408167 |
| 25 | MP0005499_abnormal_olfactory_system | 1.94625499 |
| 26 | MP0005394_taste/olfaction_phenotype | 1.94625499 |
| 27 | MP0002108_abnormal_muscle_morphology | 1.78058009 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.75362781 |
| 29 | MP0004270_analgesia | 1.72143399 |
| 30 | MP0002822_catalepsy | 1.56603385 |
| 31 | MP0000647_abnormal_sebaceous_gland | 1.38201711 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.37043109 |
| 33 | MP0004510_myositis | 1.30206123 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.29980139 |
| 35 | MP0009250_abnormal_appendicular_skeleto | 1.25099553 |
| 36 | MP0002127_abnormal_cardiovascular_syste | 1.23365698 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.22135488 |
| 38 | MP0004147_increased_porphyrin_level | 1.20705539 |
| 39 | MP0008058_abnormal_DNA_repair | 1.17707265 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 1.14041664 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.12812630 |
| 42 | MP0005330_cardiomyopathy | 1.11435461 |
| 43 | MP0006138_congestive_heart_failure | 1.09335984 |
| 44 | MP0002971_abnormal_brown_adipose | 1.08070283 |
| 45 | MP0008775_abnormal_heart_ventricle | 1.06902404 |
| 46 | MP0003385_abnormal_body_wall | 1.04466914 |
| 47 | MP0009672_abnormal_birth_weight | 1.01435383 |
| 48 | MP0004142_abnormal_muscle_tone | 0.94109343 |
| 49 | MP0002009_preneoplasia | 0.90841766 |
| 50 | MP0003137_abnormal_impulse_conducting | 0.88859472 |
| 51 | MP0002876_abnormal_thyroid_physiology | 0.87890688 |
| 52 | MP0004043_abnormal_pH_regulation | 0.87849497 |
| 53 | MP0003879_abnormal_hair_cell | 0.87360271 |
| 54 | MP0002089_abnormal_postnatal_growth/wei | 0.86372295 |
| 55 | MP0003045_fibrosis | 0.85186475 |
| 56 | MP0001661_extended_life_span | 0.84111005 |
| 57 | MP0005257_abnormal_intraocular_pressure | 0.83757742 |
| 58 | MP0002932_abnormal_joint_morphology | 0.83661167 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83482370 |
| 60 | MP0004085_abnormal_heartbeat | 0.82976079 |
| 61 | MP0002233_abnormal_nose_morphology | 0.80916160 |
| 62 | MP0004215_abnormal_myocardial_fiber | 0.78290879 |
| 63 | MP0000003_abnormal_adipose_tissue | 0.76191951 |
| 64 | MP0001324_abnormal_eye_pigmentation | 0.72240058 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 0.71321371 |
| 66 | MP0005375_adipose_tissue_phenotype | 0.68479250 |
| 67 | MP0010630_abnormal_cardiac_muscle | 0.67657807 |
| 68 | MP0005334_abnormal_fat_pad | 0.67533068 |
| 69 | MP0009703_decreased_birth_body | 0.66383649 |
| 70 | MP0002972_abnormal_cardiac_muscle | 0.66215367 |
| 71 | MP0002638_abnormal_pupillary_reflex | 0.65234124 |
| 72 | MP0001293_anophthalmia | 0.64993344 |
| 73 | MP0004484_altered_response_of | 0.63629148 |
| 74 | MP0004084_abnormal_cardiac_muscle | 0.63302597 |
| 75 | MP0005666_abnormal_adipose_tissue | 0.63266845 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 0.62851986 |
| 77 | MP0002249_abnormal_larynx_morphology | 0.60717762 |
| 78 | MP0003195_calcinosis | 0.56660068 |
| 79 | MP0000266_abnormal_heart_morphology | 0.55989838 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.54468795 |
| 81 | MP0005197_abnormal_uvea_morphology | 0.53888192 |
| 82 | MP0006035_abnormal_mitochondrial_morpho | 0.53195576 |
| 83 | MP0001544_abnormal_cardiovascular_syste | 0.52976658 |
| 84 | MP0005385_cardiovascular_system_phenoty | 0.52976658 |
| 85 | MP0003763_abnormal_thymus_physiology | 0.52897538 |
| 86 | MP0001727_abnormal_embryo_implantation | 0.52747042 |
| 87 | MP0003755_abnormal_palate_morphology | 0.52424150 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.51988620 |
| 89 | MP0000762_abnormal_tongue_morphology | 0.50657975 |
| 90 | MP0002114_abnormal_axial_skeleton | 0.49995949 |
| 91 | MP0005266_abnormal_metabolism | 0.49728848 |
| 92 | MP0002132_abnormal_respiratory_system | 0.49601545 |
| 93 | MP0005386_behavior/neurological_phenoty | 0.48653716 |
| 94 | MP0004924_abnormal_behavior | 0.48653716 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.47960176 |
| 96 | MP0002184_abnormal_innervation | 0.47821631 |
| 97 | MP0005535_abnormal_body_temperature | 0.46240645 |
| 98 | MP0003828_pulmonary_edema | 0.45345113 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.43615245 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.42779075 |
| 101 | MP0003948_abnormal_gas_homeostasis | 0.42719991 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.41230603 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.40624751 |
| 104 | MP0002081_perinatal_lethality | 0.40566194 |
| 105 | MP0005332_abnormal_amino_acid | 0.40543625 |
| 106 | MP0005083_abnormal_biliary_tract | 0.40102638 |
| 107 | MP0002734_abnormal_mechanical_nocicepti | 0.40042584 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.39079827 |
| 109 | MP0005423_abnormal_somatic_nervous | 0.38990495 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.38275257 |
| 111 | MP0004133_heterotaxia | 0.37858606 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.37551213 |
| 113 | MP0001346_abnormal_lacrimal_gland | 0.37462898 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.37183571 |
| 115 | MP0000049_abnormal_middle_ear | 0.37145297 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.37144568 |
| 117 | MP0006276_abnormal_autonomic_nervous | 0.37096468 |
| 118 | MP0002109_abnormal_limb_morphology | 0.36915722 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.35865606 |
| 120 | MP0005365_abnormal_bile_salt | 0.34730145 |
| 121 | MP0002272_abnormal_nervous_system | 0.34607711 |
| 122 | MP0008569_lethality_at_weaning | 0.34570440 |
| 123 | MP0010030_abnormal_orbit_morphology | 0.34324673 |
| 124 | MP0002933_joint_inflammation | 0.34170020 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.33927296 |
| 126 | MP0001986_abnormal_taste_sensitivity | 0.33607673 |
| 127 | MP0001440_abnormal_grooming_behavior | 0.33182921 |
| 128 | MP0009115_abnormal_fat_cell | 0.32687250 |
| 129 | MP0001984_abnormal_olfaction | 0.32261722 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.31594799 |
| 131 | MP0005670_abnormal_white_adipose | 0.30803297 |
| 132 | MP0002066_abnormal_motor_capabilities/c | 0.30603132 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.30572056 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.30447587 |
| 135 | MP0001943_abnormal_respiration | 0.30211502 |
| 136 | MP0001286_abnormal_eye_development | 0.29491696 |
| 137 | MP0005452_abnormal_adipose_tissue | 0.29328749 |
| 138 | MP0001299_abnormal_eye_distance/ | 0.28948673 |
| 139 | MP0002697_abnormal_eye_size | 0.28097472 |
| 140 | MP0010329_abnormal_lipoprotein_level | 0.28066421 |
| 141 | MP0001501_abnormal_sleep_pattern | 0.25947770 |
| 142 | MP0002163_abnormal_gland_morphology | 0.25644415 |
| 143 | MP0005319_abnormal_enzyme/_coenzyme | 0.25488148 |
| 144 | MP0003011_delayed_dark_adaptation | 0.25256765 |
| 145 | MP0002102_abnormal_ear_morphology | 0.25153880 |
| 146 | MP0008872_abnormal_physiological_respon | 0.23829565 |
| 147 | MP0005551_abnormal_eye_electrophysiolog | 0.23123776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.96543644 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.62277152 |
| 3 | Exercise-induced myalgia (HP:0003738) | 8.01618217 |
| 4 | Nemaline bodies (HP:0003798) | 7.84928682 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 7.18343377 |
| 6 | Pelvic girdle muscle weakness (HP:0003749) | 7.08511608 |
| 7 | Abnormality of the hip-girdle musculature (HP:0001445) | 6.52652570 |
| 8 | Abnormality of the musculature of the pelvis (HP:0001469) | 6.52652570 |
| 9 | Distal arthrogryposis (HP:0005684) | 6.35092644 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 6.32639104 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 6.20972285 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.14302264 |
| 13 | Myopathic facies (HP:0002058) | 5.93000881 |
| 14 | Round ear (HP:0100830) | 5.81637084 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 5.35680167 |
| 16 | Calcaneovalgus deformity (HP:0001848) | 5.05133193 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.72846438 |
| 18 | Muscle fiber splitting (HP:0003555) | 4.69674952 |
| 19 | Myoglobinuria (HP:0002913) | 4.59641046 |
| 20 | Deformed tarsal bones (HP:0008119) | 4.59564233 |
| 21 | Difficulty running (HP:0009046) | 4.47579645 |
| 22 | Muscle stiffness (HP:0003552) | 4.19938969 |
| 23 | Hyporeflexia of lower limbs (HP:0002600) | 4.11981817 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 3.90277271 |
| 25 | Rhabdomyolysis (HP:0003201) | 3.87695319 |
| 26 | Limb-girdle muscle weakness (HP:0003325) | 3.85938999 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.85014376 |
| 28 | Increased connective tissue (HP:0009025) | 3.72029794 |
| 29 | Abnormality of the calf musculature (HP:0001430) | 3.33846457 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.32322113 |
| 31 | Subaortic stenosis (HP:0001682) | 3.32322113 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.31971311 |
| 33 | Myotonia (HP:0002486) | 3.29808339 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.16356677 |
| 35 | Malignant hyperthermia (HP:0002047) | 3.11895695 |
| 36 | Shoulder girdle muscle weakness (HP:0003547) | 3.10077757 |
| 37 | Abnormality of the calcaneus (HP:0008364) | 3.06700815 |
| 38 | Frequent falls (HP:0002359) | 2.83168227 |
| 39 | Bundle branch block (HP:0011710) | 2.78033171 |
| 40 | Areflexia of lower limbs (HP:0002522) | 2.78014049 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.70491756 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64628386 |
| 43 | Hyperkalemia (HP:0002153) | 2.62764467 |
| 44 | Slender build (HP:0001533) | 2.62557138 |
| 45 | Neck muscle weakness (HP:0000467) | 2.60932834 |
| 46 | Palpebral edema (HP:0100540) | 2.56640402 |
| 47 | Difficulty climbing stairs (HP:0003551) | 2.45791320 |
| 48 | Mesomelia (HP:0003027) | 2.34648628 |
| 49 | Bell-shaped thorax (HP:0001591) | 2.32294449 |
| 50 | Asymmetric septal hypertrophy (HP:0001670) | 2.31826290 |
| 51 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.29163078 |
| 52 | Abnormality of the neuromuscular junction (HP:0003398) | 2.28939148 |
| 53 | Fatigable weakness (HP:0003473) | 2.28939148 |
| 54 | Foot dorsiflexor weakness (HP:0009027) | 2.25915056 |
| 55 | Abnormality of the intervertebral disk (HP:0005108) | 2.25080074 |
| 56 | Mask-like facies (HP:0000298) | 2.23275223 |
| 57 | Dilated cardiomyopathy (HP:0001644) | 2.21986902 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.08702211 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.05059578 |
| 60 | Hip contracture (HP:0003273) | 2.04943417 |
| 61 | Cone-rod dystrophy (HP:0000548) | 2.03938642 |
| 62 | Exercise intolerance (HP:0003546) | 2.02179894 |
| 63 | Ulnar deviation of finger (HP:0009465) | 1.98756708 |
| 64 | Waddling gait (HP:0002515) | 1.98559863 |
| 65 | Ventricular tachycardia (HP:0004756) | 1.98509597 |
| 66 | Nonprogressive disorder (HP:0003680) | 1.97580810 |
| 67 | Lipoatrophy (HP:0100578) | 1.97066831 |
| 68 | Fetal akinesia sequence (HP:0001989) | 1.96935365 |
| 69 | Metatarsus adductus (HP:0001840) | 1.96270282 |
| 70 | Distal lower limb amyotrophy (HP:0008944) | 1.95696638 |
| 71 | Hypoplastic ischia (HP:0003175) | 1.94819765 |
| 72 | Paralysis (HP:0003470) | 1.93580094 |
| 73 | Scapular winging (HP:0003691) | 1.93524938 |
| 74 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.91141972 |
| 75 | Proximal amyotrophy (HP:0007126) | 1.88912877 |
| 76 | Sudden death (HP:0001699) | 1.88385205 |
| 77 | Weak cry (HP:0001612) | 1.88040778 |
| 78 | Type 2 muscle fiber atrophy (HP:0003554) | 1.87843471 |
| 79 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.87563107 |
| 80 | Febrile seizures (HP:0002373) | 1.85854517 |
| 81 | Wrist flexion contracture (HP:0001239) | 1.85703401 |
| 82 | Hyperuricemia (HP:0002149) | 1.85416738 |
| 83 | Increased purine levels (HP:0004368) | 1.85416738 |
| 84 | Heart block (HP:0012722) | 1.84882988 |
| 85 | Narrow face (HP:0000275) | 1.84378048 |
| 86 | Increased density of long bones (HP:0006392) | 1.83301148 |
| 87 | Bulbar palsy (HP:0001283) | 1.81992818 |
| 88 | Broad-based gait (HP:0002136) | 1.81301237 |
| 89 | Hypothermia (HP:0002045) | 1.80658534 |
| 90 | Abnormality of lateral ventricle (HP:0030047) | 1.80065474 |
| 91 | Atonic seizures (HP:0010819) | 1.79862275 |
| 92 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78537871 |
| 93 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78135149 |
| 94 | EMG: neuropathic changes (HP:0003445) | 1.76390382 |
| 95 | Spinal rigidity (HP:0003306) | 1.72728063 |
| 96 | Popliteal pterygium (HP:0009756) | 1.71628066 |
| 97 | Limb-girdle muscle atrophy (HP:0003797) | 1.68925296 |
| 98 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.67539462 |
| 99 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 1.67220462 |
| 100 | Muscle fiber atrophy (HP:0100295) | 1.65649578 |
| 101 | Abnormality of the ischium (HP:0003174) | 1.65400533 |
| 102 | Hypoalphalipoproteinemia (HP:0003233) | 1.64188135 |
| 103 | Abnormal atrioventricular conduction (HP:0005150) | 1.64095926 |
| 104 | Generalized muscle weakness (HP:0003324) | 1.62098214 |
| 105 | Increased intramyocellular lipid droplets (HP:0012240) | 1.61868108 |
| 106 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.61135893 |
| 107 | Oligomenorrhea (HP:0000876) | 1.61023974 |
| 108 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.57725196 |
| 109 | Muscular dystrophy (HP:0003560) | 1.57413781 |
| 110 | Anosmia (HP:0000458) | 1.54845237 |
| 111 | Stridor (HP:0010307) | 1.54135167 |
| 112 | Generalized tonic-clonic seizures (HP:0002069) | 1.51491516 |
| 113 | Long clavicles (HP:0000890) | 1.50948619 |
| 114 | Ventricular arrhythmia (HP:0004308) | 1.47412474 |
| 115 | Gowers sign (HP:0003391) | 1.45905370 |
| 116 | Increased muscle lipid content (HP:0009058) | 1.43669448 |
| 117 | Rocker bottom foot (HP:0001838) | 1.43314512 |
| 118 | Ragged-red muscle fibers (HP:0003200) | 1.42473248 |
| 119 | Hypochromic microcytic anemia (HP:0004840) | 1.42220451 |
| 120 | Facial diplegia (HP:0001349) | 1.42161100 |
| 121 | Abnormality of potassium homeostasis (HP:0011042) | 1.38691756 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.34301816 |
| 123 | Left ventricular hypertrophy (HP:0001712) | 1.33002044 |
| 124 | Limited hip movement (HP:0008800) | 1.29042214 |
| 125 | Steppage gait (HP:0003376) | 1.27498333 |
| 126 | Neonatal hypotonia (HP:0001319) | 1.26906047 |
| 127 | Acute necrotizing encephalopathy (HP:0006965) | 1.25768604 |
| 128 | Delayed gross motor development (HP:0002194) | 1.23831092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERBB3 | 8.55761443 |
| 2 | BMPR2 | 6.55564698 |
| 3 | PLK4 | 6.09867331 |
| 4 | OBSCN | 4.39266411 |
| 5 | TTN | 3.98936395 |
| 6 | INSRR | 3.78800363 |
| 7 | PHKG1 | 3.40657421 |
| 8 | PHKG2 | 3.40657421 |
| 9 | BLK | 3.05556263 |
| 10 | NME1 | 2.14888578 |
| 11 | PLK2 | 2.10180697 |
| 12 | CDK19 | 1.84510599 |
| 13 | NEK9 | 1.84092313 |
| 14 | MUSK | 1.80774557 |
| 15 | SIK2 | 1.68493460 |
| 16 | PIK3CG | 1.58270996 |
| 17 | MAPKAPK3 | 1.45104496 |
| 18 | FRK | 1.41883357 |
| 19 | MAP2K3 | 1.30674627 |
| 20 | MAP3K7 | 1.27201325 |
| 21 | SIK1 | 1.24400410 |
| 22 | MARK1 | 1.06459438 |
| 23 | MAP2K4 | 1.04225966 |
| 24 | DMPK | 0.91675100 |
| 25 | MAP4K2 | 0.91219057 |
| 26 | PIK3CA | 0.83743168 |
| 27 | SIK3 | 0.81987500 |
| 28 | TNK2 | 0.80729311 |
| 29 | CCNB1 | 0.76205926 |
| 30 | NEK1 | 0.74990452 |
| 31 | TRIB3 | 0.74968243 |
| 32 | MOS | 0.73033750 |
| 33 | CDK6 | 0.71807910 |
| 34 | MAPK12 | 0.71677132 |
| 35 | TGFBR2 | 0.70612999 |
| 36 | IRAK4 | 0.64510120 |
| 37 | CAMK1 | 0.63781668 |
| 38 | BMPR1B | 0.62028427 |
| 39 | PRKAA1 | 0.60728631 |
| 40 | EEF2K | 0.60654665 |
| 41 | DAPK2 | 0.58400895 |
| 42 | MAP2K6 | 0.58377441 |
| 43 | MAPK7 | 0.56183836 |
| 44 | ZAK | 0.55870808 |
| 45 | TNIK | 0.55415474 |
| 46 | OXSR1 | 0.52299958 |
| 47 | CAMK2A | 0.52043302 |
| 48 | TYK2 | 0.51519192 |
| 49 | BRD4 | 0.50094118 |
| 50 | TIE1 | 0.44962145 |
| 51 | MAP2K1 | 0.44924305 |
| 52 | MAP3K13 | 0.44813907 |
| 53 | MAP3K10 | 0.44608970 |
| 54 | PRKAA2 | 0.44010625 |
| 55 | CAMK1G | 0.43198007 |
| 56 | PDK2 | 0.42528648 |
| 57 | PRKACA | 0.41417126 |
| 58 | MAP3K6 | 0.40881717 |
| 59 | NTRK2 | 0.39708534 |
| 60 | ADRBK2 | 0.38873646 |
| 61 | PKN2 | 0.38819854 |
| 62 | GSK3A | 0.37529447 |
| 63 | TLK1 | 0.37300094 |
| 64 | BCKDK | 0.36718065 |
| 65 | AKT2 | 0.33446139 |
| 66 | CAMK2B | 0.32943151 |
| 67 | ROCK1 | 0.31660886 |
| 68 | MAPKAPK5 | 0.31172282 |
| 69 | TRPM7 | 0.30326877 |
| 70 | PNCK | 0.30102604 |
| 71 | STK4 | 0.29289520 |
| 72 | DYRK1B | 0.29266483 |
| 73 | GRK1 | 0.27563004 |
| 74 | SGK2 | 0.27492388 |
| 75 | CSF1R | 0.27020298 |
| 76 | STK24 | 0.26974872 |
| 77 | MAPK15 | 0.26919778 |
| 78 | PTK2B | 0.26798524 |
| 79 | ZAP70 | 0.26716704 |
| 80 | PDK4 | 0.26044417 |
| 81 | PDK3 | 0.26044417 |
| 82 | NLK | 0.25336280 |
| 83 | TBK1 | 0.24416511 |
| 84 | LIMK1 | 0.23723328 |
| 85 | CDK4 | 0.23442663 |
| 86 | PTK6 | 0.21383175 |
| 87 | WNK4 | 0.21229167 |
| 88 | PRKCQ | 0.19846648 |
| 89 | RPS6KB1 | 0.19785661 |
| 90 | MAP3K4 | 0.19033142 |
| 91 | CAMK2G | 0.18801399 |
| 92 | CASK | 0.18586318 |
| 93 | PKN1 | 0.18388838 |
| 94 | PINK1 | 0.18185045 |
| 95 | WNK3 | 0.18031055 |
| 96 | MAPKAPK2 | 0.17413351 |
| 97 | CDK9 | 0.17349169 |
| 98 | RPS6KA6 | 0.17337662 |
| 99 | EPHA3 | 0.17297309 |
| 100 | RPS6KA1 | 0.16180769 |
| 101 | DYRK3 | 0.16083188 |
| 102 | ACVR1B | 0.15224117 |
| 103 | MARK2 | 0.15150315 |
| 104 | PRKACG | 0.14564559 |
| 105 | PAK3 | 0.14131225 |
| 106 | PRKD1 | 0.13663676 |
| 107 | GRK6 | 0.12319743 |
| 108 | NEK2 | 0.11669688 |
| 109 | GRK7 | 0.11198592 |
| 110 | PRKG1 | 0.10899125 |
| 111 | MAPK8 | 0.10896487 |
| 112 | STK39 | 0.10735162 |
| 113 | CSNK1D | 0.10305328 |
| 114 | MAP2K2 | 0.10059482 |
| 115 | PDK1 | 0.09797687 |
| 116 | MAPK11 | 0.09785632 |
| 117 | ADRBK1 | 0.09623210 |
| 118 | FGFR3 | 0.09556866 |
| 119 | NTRK3 | 0.09373819 |
| 120 | RPS6KL1 | 0.09300757 |
| 121 | RPS6KC1 | 0.09300757 |
| 122 | TAOK3 | 0.08950960 |
| 123 | MAPK4 | 0.08734893 |
| 124 | SGK1 | 0.08507445 |
| 125 | CSNK1A1 | 0.08236406 |
| 126 | MAP3K5 | 0.07819299 |
| 127 | STK11 | 0.07728022 |
| 128 | MAPK9 | 0.07588499 |
| 129 | STK3 | 0.07078824 |
| 130 | SGK223 | 0.05600355 |
| 131 | SYK | 0.05065874 |
| 132 | YES1 | 0.04837351 |
| 133 | CDK11A | 0.04588740 |
| 134 | IRAK2 | 0.03229416 |
| 135 | CSNK1G2 | 0.03000660 |
| 136 | CLK1 | 0.02861079 |
| 137 | JAK2 | 0.02164834 |
| 138 | MAPK13 | 0.02091851 |
| 139 | CDK15 | 0.02045638 |
| 140 | HCK | 0.01824250 |
| 141 | MAPK10 | 0.01632890 |
| 142 | MARK3 | 0.01469613 |
| 143 | CAMK2D | 0.01460142 |
| 144 | INSR | 0.01322580 |
| 145 | CDK14 | 0.00453889 |
| 146 | RPS6KA3 | 0.00073032 |
| 147 | SGK3 | -0.0265854 |
| 148 | TXK | -0.0160347 |
| 149 | JAK1 | -0.0132742 |
| 150 | CAMK4 | -0.0115199 |
| 151 | PRKACB | -0.0112898 |
| 152 | CDK18 | -0.0073953 |
| 153 | PLK3 | -0.0071581 |
| 154 | MAP2K7 | -0.0020381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.34977595 |
| 2 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.03661412 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.62698071 |
| 4 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.50548662 |
| 5 | FoxO signaling pathway_Homo sapiens_hsa04068 | 2.46357179 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.44300609 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.43790196 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26969747 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14922730 |
| 10 | Insulin resistance_Homo sapiens_hsa04931 | 2.13265110 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.09028960 |
| 12 | Adherens junction_Homo sapiens_hsa04520 | 2.08150164 |
| 13 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.06599649 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.05745940 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.01618422 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99932732 |
| 17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.98558097 |
| 18 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.93175404 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.91483584 |
| 20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.89505148 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.72797259 |
| 22 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.65341499 |
| 23 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.54954520 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.47470317 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45078768 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44382846 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41116733 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41009003 |
| 29 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.40877966 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36288015 |
| 31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.35379565 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.32374477 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29536619 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27102296 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.26765122 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.26268511 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.24984639 |
| 38 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.24257537 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.23928073 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23198654 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21007123 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.18887947 |
| 43 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.18033922 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.17152282 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14667619 |
| 46 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13911308 |
| 47 | Endometrial cancer_Homo sapiens_hsa05213 | 1.10390963 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09398818 |
| 49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09307373 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.07480749 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.07120476 |
| 52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06412333 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06018625 |
| 54 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04921707 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03159218 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 1.02140887 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98734880 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97422881 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96455163 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.96299425 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94679659 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.94605844 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92322755 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90558403 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89723378 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89397513 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86937062 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86828799 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83235029 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81695105 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81368232 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78650894 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78216489 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78076346 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77622725 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77133706 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76265328 |
| 78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74306208 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71939590 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71422490 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.71035403 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.70968866 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69920990 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69844777 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.68878017 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.68770162 |
| 87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.66548391 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65199960 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64191666 |
| 90 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63947472 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.63291712 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.62883187 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.60552634 |
| 94 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60009919 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.59962853 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59777083 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59510842 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59065846 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58452023 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58167169 |
| 101 | Long-term depression_Homo sapiens_hsa04730 | 0.57684169 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57152636 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.55904585 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55894445 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54826169 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52987834 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52512091 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50801288 |
| 109 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50716661 |
| 110 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49665802 |
| 111 | Apoptosis_Homo sapiens_hsa04210 | 0.48995360 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48293377 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47995400 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46772056 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46013666 |
| 116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45523455 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43261303 |
| 118 | Prostate cancer_Homo sapiens_hsa05215 | 0.43215705 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42614810 |
| 120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41183008 |
| 121 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.40977499 |
| 122 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40121341 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39394669 |
| 124 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38649354 |
| 125 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37361757 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37168230 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35138382 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34897728 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34156903 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33453689 |
| 131 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.31934724 |
| 132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31574885 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30855459 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29341397 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28522297 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28507921 |
| 137 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28154782 |
| 138 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.28003811 |
| 139 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27362444 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.27263106 |
| 141 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.26247430 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22789249 |
| 143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.21520425 |
| 144 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18420302 |
| 145 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17928580 |
| 146 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.17165167 |
| 147 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15191284 |
| 148 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.15047747 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.14888106 |

